(ORGO) Organogenesis Holdings - Performance 55.4% in 12m
ORGO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-1.98%
#35 in Peer-Group
Rel. Strength
87.98%
#925 in Stock-Universe
Total Return 12m
55.36%
#23 in Peer-Group
Total Return 5y
17.08%
#31 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 12.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 6.21 USD |
| 52 Week Low | 2.42 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.17 |
| Buy/Sell Signal +-5 | 1.48 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ORGO (55.4%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ORGO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ORGO
| Total Return (including Dividends) | ORGO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 38.58% | 5.89% | 3.54% |
| 3 Months | 3.70% | 15.34% | 16.07% |
| 12 Months | 55.36% | -11.61% | 12.18% |
| 5 Years | 17.08% | -23.80% | 107.69% |
| Trend Score (consistency of price movement) | ORGO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 96.8% | 65.7% | 91.4% |
| 3 Months | -22.5% | 79.4% | 97.5% |
| 12 Months | 58% | -87.3% | 46.7% |
| 5 Years | -60.3% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th93.00 | 30.88% | 33.28% |
| 3 Month | %th29.50 | -10.09% | -10.79% |
| 12 Month | %th88.50 | 75.78% | 37.91% |
| 5 Years | %th85.00 | 53.64% | -44.03% |
FAQs
Does Organogenesis Holdings (ORGO) outperform the market?
Yes,
over the last 12 months ORGO made 55.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ORGO made 3.70%, while XBI made 15.34%.
Performance Comparison ORGO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ORGO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.4% | 35% | 49.8% | 43% |
| US NASDAQ 100 | QQQ | 4.9% | 34.4% | 45% | 43% |
| German DAX 40 | DAX | 5.3% | 36.6% | 36.7% | 26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.8% | 33.6% | 45.8% | 36% |
| Hongkong Hang Seng | HSI | 4.8% | 36.1% | 27.8% | 21% |
| India NIFTY 50 | INDA | 7.1% | 38% | 48.4% | 59% |
| Brasil Bovespa | EWZ | 10% | 41.6% | 37.7% | 55% |
ORGO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.6% | 35.7% | 42.7% | 30% |
| Consumer Discretionary | XLY | 3.9% | 34.5% | 54.6% | 38% |
| Consumer Staples | XLP | 7.2% | 38.3% | 48.3% | 48% |
| Energy | XLE | 3.4% | 37.4% | 57.2% | 56% |
| Financial | XLF | 5.9% | 34.2% | 45.7% | 31% |
| Health Care | XLV | 5.2% | 38.6% | 58.1% | 62% |
| Industrial | XLI | 4.2% | 33.1% | 42.4% | 33% |
| Materials | XLB | 5.1% | 34.8% | 48.8% | 53% |
| Real Estate | XLRE | 4.8% | 37.9% | 49.2% | 48% |
| Technology | XLK | 5.4% | 33.2% | 42.7% | 45% |
| Utilities | XLU | 4.7% | 35.7% | 44.4% | 33% |
| Aerospace & Defense | XAR | 2.6% | 28.7% | 26.8% | 6% |
| Biotech | XBI | 0% | 32.7% | 53.5% | 67% |
| Homebuilder | XHB | 2.8% | 29.3% | 57.6% | 59% |
| Retail | XRT | 4.6% | 33.5% | 50.7% | 48% |
ORGO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.8% | 42.4% | 62.8% | 61% |
| Natural Gas | UNG | 4.5% | 48.5% | 72.6% | 50% |
| Gold | GLD | 4.8% | 40.2% | 32.1% | 18% |
| Silver | SLV | 2.1% | 33.7% | 28% | 32% |
| Copper | CPER | 4.1% | 25% | 31.1% | 33% |
ORGO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.3% | 38% | 52.8% | 59% |
| iShares High Yield Corp. Bond | HYG | 5.8% | 37.7% | 51.7% | 47% |